OPEN END-TURBO-OPTIONSSCHEIN - INCYTE CO. | Market Closed - BOERSE MUENCHEN 01:07:35 01/06/2024 am IST | ||
| 0.91 EUR | +2.25% |
|
| 3 months | -19.47% | ||
| 6 months | +16.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
INCYTE CORPORATION
Latest news about INCYTE CORPORATION
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 0.91 | +2.25% |
| 30/24/30 | 0.89 | +4.71% |
| 29/24/29 | 0.85 | -1.16% |
| 28/24/28 | 0.86 | -5.49% |
| 27/24/27 | 0.91 | -.--% |
Real-time BOERSE MUENCHEN
Last update May 01, 2024 at 01:07 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | INCYTE CORPORATION |
| Issuer | HSBC |
| WKN | HG99HY |
| ISIN | DE000HG99HY4 |
| Date issued | 08/05/2023 |
| Strike | 47.99 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.18 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.17 € |
|---|---|
| Lowest since issue | 0.35 € |
Company Profile
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows:
- product sales (85.6%);
- royalties (14.2%);
- income from research and cooperation agreements (0.2%).
Sector
-
Consensus: Incyte Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
57.79
USD
Average target price
72.8
USD
Spread / Average Target
+25.97%
- Stock Market
- Certificates
- Certificat
